Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis

• Status: Completed
• Trial end date: 2017-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine in children with persistent AR the effect of the topically applied beclomethasone in comparison with cetirizine on nasal patency evaluated by acoustic rhinometry and subjective nasal symptoms.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stefania La Grutta, MD
• Treatments: Beclomethasone

Criteria

Inclusion Criteria:

• children 6-16 years of age with a history of AR in the previous year

• T5SS: ≥5 in the last week before enrollment

Exclusion Criteria:

• asthma symptoms

• acute upper respiratory infections

• anatomic nasal defects (ie, septum deviation), or nasal polyps

• use in the past 4 weeks of nasal or oral corticosteroids, nasal or oral decongestants, antihistamines.